News & Articles

Explore topics from therapeutic antibodies and advances in COVID-19 sample prep to neonatal hypocalcemia and cytotoxicity assay development

Find out how to overcome the challenges involved with establishing reference intervals for clinical interpretation in this on-demand webinar

Arvind Kothandaraman discusses the importance of detecting new SARS-CoV-2 variants and future trends in COVID-19 diagnostics

Advancement can enable greater certainty for providers and better outcomes for patients

The acquisition aims to meet continuing demand for COVID-related testing as well as develop point-of care tests for future infectious diseases

Learn about why patients are admitted to an ICU, the physiological support, monitoring, and treatments available and the impact COVID-19 globally

Take a look back at the technologies, innovations and clinical advances that hit the headlines over the past 12 months

The Access SARS-CoV-2 Antigen assay is offered to healthcare providers at $4, making reliable and frequent mass testing affordable

Explore ways to improve time to result in critical pathways such as sepsis

Parties to collaborate on development, commercialization, and supply of the Orgenesis therapies pipeline

The collaboration aims to secure manufacturing and testing capacity in the next phase of the pandemic

Test adds to QIAGEN’s growing portfolio of PCR testing solutions for COVID-19 testing

QIAreach SARS-CoV-2 Antigen Test is an important step towards decentralized mass screening by processing samples in 2–15 minutes

The kit promises to be a low cost, high-sensitivity diagnostic test for COVID-19 detection

The new IgM antibody test demonstrated 99.9% specificity with 1,400 negative samples and 100% sensitivity at >18 days post symptom onset and post positive PCR